Recent studies have highlighted the global prevalence of metabolic syndrome, driven by the rise in obesity and type 2 diabetes. The World Health Organization (WHO) and other major health organizations define metabolic syndrome with criteria that include central obesity, insulin resistance, hypertension, and dyslipidemia. As of 2015, metabolic syndrome affects approximately 25% of the global population, with rates significantly higher in urban areas due to increased consumption of high-calorie, low-nutrient diets and decreased physical activity. This condition is associated with a threefold increase in the risk of type 2 diabetes and cardiovascular disease, accounting for a substantial burden of non-communicable diseases globally (Saklayen, 2018).
Recent studies have highlighted the global prevalence of metabolic syndrome driven by the rise in obesity and type 2 diabetes The World Health Organization (WHO) and other major health organizations define metabolic syndrome with criteria that include central obesity insulin resistance hypertension and dyslipidemia As of 2015 metabolic syndrome affects approximately 25% of the global population with rates significantly higher in urban areas due to increased consumption of high-calorie low-nutrient diets and decreased physical activity This condition is associated with a threefold increase in the risk of type 2 diabetes and cardiovascular disease accounting for a substantial burden of non-communicable diseases globally (Saklayen 2018)